Single Dose of Cervarix Vaccine in Girls or Three Doses of Gardasil Vaccine in Women for the Prevention of Human Papillomavirus Infection, the PRIMAVERA-ESCUDDO Trial

Inclusion Criteria: * Aged between: * 9 and 14 years inclusive for Cervarix group * 18 and 25 years inclusive for Gardasil group * Living in the study area without plans to move outside the country in the next six months * Able to communicate with study personnel * Able and willing to provide a blood sample * Willing to permit export of blood samples to the United States * Willing to participate in the study and: * If Cervarix group and less than 12 years old, receive study information and be supported in study participation by at least one of parent (or guardian), who is willing to sign the informed consent document * If Cervarix group and 12 years old or older, sign the informed assent and be supported in study participation by at least one parent (or guardian), who is willing to sign the informed consent document * If Gardasil group, sign the informed consent * In good health as determined by a medical history (physical exam will be conducted if necessary per the doctor's criterion) Exclusion Criteria: * They have a diagnosis of an autoimmune, degenerative, or neurological disease without treatment or adequate control; a progressive or severe neurological disease; a genetic immunodeficiency; or any other serious chronic disease without treatment and / or adequate control that, according to the principal investigator or designee, for which vaccination is contraindicated (NOTE: Potential participants with these conditions can be included after consultation wit…